ImprimisRx NJ recalls Timolol- Dorzolamide- Latanoprost P-F (0.5/2.0/0.005%) ophthalmic drops, packaged in 5mL bottles, Rx only, ImprimisRx N…

Recall date

July 17, 2019

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-1579-2019

FDA classification

Class II

Brand / firm

ImprimisRx NJ

Sold / distributed

Nationwide within the United States

Why it was recalled

Subpotent Drug

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Timolol- Dorzolamide- Latanoprost P-F (0.5/2.0/0.005%) ophthalmic drops, packaged in 5mL bottles, Rx only, ImprimisRx NJ 1705 Route 46 West, Suite 4, Ledgewood, NJ 07852 (844) 446-6979